Australian Equity Long Short, JCP Investment Partners

Jai Mirchandani

Australian Equity Long Short

Combining the art and science of investing

JCP Investment Partners

JCP is a research-driven, fundamental Australian Equities investment manager. We were founded in 1998 and are 100% owned by our employees, directors and associates. With almost 20 years of organisational experience we have a proven performance record in both bull and bear markets. Our alignment policy is based on the principles of employee ownership and co-investment.

We recognise the value in retaining an experienced and stable team, together with operating within a theoretically robust and proven investment framework. At the heart of our investment process is our commitment to maintaining a large ‘in-house’ research team, which is supplemented by proprietary external research. 

Our competitive advantage lies in our ability to combine the art and science of investing, providing an edge that is difficult for other investors to replicate.  

Our business strategy is to deliver long-term excess returns to our clients and maximise returns to our shareholders, within an entrepreneurial culture that allows our employees to achieve their full potential.
JCP’s proprietary investment platform allows for efficient processing of our research insights, and more efficient idea generation through our smart optimisation platform.  We then combine this with a sensible qualitative overlay through the experience and ‘gut feel’ of our Portfolio Construction team. 

We believe the sophistication of our process is a source of enduring competitive advantage, enabling us to continue to generate long-term excess returns for our clients. The flexibility and scalability of our resources, provide us with the tools to have meaningful conversations with our clients about their needs and how we can create solutions to better meet these needs.

JCP holds Australian Financial Services Licence No. 247132.

Equity Bottom-Up

Cochlear announced their first half 2018 result on 13th February 2018.<ul><li>Cochlear implant units decreased 2%</li><li>Sales revenue increased 7% in constant currency (cc)</li><li>Earnings before interest and tax (EBIT) increased 4% cc</li><li>Net profit increased 1% cc</li><li>Maintained FY18 NPAT guidance of $240-250m, a 7-12% increase on FY17</li></ul>

Cochlear announced their first half 2018 result on 13th February 2018.Cochlear implant units decreased 2%Sales revenue increased 7% in constant currency (cc)Earnings before interest and tax (EBIT) increased 4% ccNet profit increased 1% ccMaintained FY18 NPAT guidance of $240-250m, a 7-12% increase on FY17

Cochlear 1H18 Result. Weak First Half, but Thesis Still in Place

Cochlear Ltd

Cochlear 1H18 Result. Weak First Half, but Thesis Still in Place